BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 27742770)

  • 21. RNA sequencing reveals resistance of TLR4 ligand-activated microglial cells to inflammation mediated by the selective jumonji H3K27 demethylase inhibitor.
    Das A; Arifuzzaman S; Yoon T; Kim SH; Chai JC; Lee YS; Jung KH; Chai YG
    Sci Rep; 2017 Jul; 7(1):6554. PubMed ID: 28747667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological targeting of KDM6A and KDM6B, as a novel therapeutic strategy for treating craniosynostosis in Saethre-Chotzen syndrome.
    Pribadi C; Camp E; Cakouros D; Anderson P; Glackin C; Gronthos S
    Stem Cell Res Ther; 2020 Dec; 11(1):529. PubMed ID: 33298158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism.
    Cribbs AP; Terlecki-Zaniewicz S; Philpott M; Baardman J; Ahern D; Lindow M; Obad S; Oerum H; Sampey B; Mander PK; Penn H; Wordsworth P; Bowness P; de Winther M; Prinjha RK; Feldmann M; Oppermann U
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6056-6066. PubMed ID: 32123118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-9 promotes cell survival and drug resistance in diffuse large B-cell lymphoma.
    Lv X; Feng L; Ge X; Lu K; Wang X
    J Exp Clin Cancer Res; 2016 Jul; 35(1):106. PubMed ID: 27364124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kdm6a and Kdm6b: Altered expression in malignant pleural mesothelioma.
    Cregan S; Breslin M; Roche G; Wennstedt S; MacDonagh L; Albadri C; Gao Y; O'Byrne KJ; Cuffe S; Finn SP; Gray SG
    Int J Oncol; 2017 Mar; 50(3):1044-1052. PubMed ID: 28197626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of JMJD3 Demethylase and Its Inhibitor GSK-J4 in Regulation of
    Sanchez A; El Ouardi D; Houfaf Khoufaf FZ; Idrissou M; Boisnier T; Penault-Llorca F; Bignon YJ; Guy L; Bernard-Gallon D
    OMICS; 2020 Aug; 24(8):505-507. PubMed ID: 32525734
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma.
    Hashizume R; Andor N; Ihara Y; Lerner R; Gan H; Chen X; Fang D; Huang X; Tom MW; Ngo V; Solomon D; Mueller S; Paris PL; Zhang Z; Petritsch C; Gupta N; Waldman TA; James CD
    Nat Med; 2014 Dec; 20(12):1394-6. PubMed ID: 25401693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The histone demethylase KDM6B in the medial prefrontal cortex epigenetically regulates cocaine reward memory.
    Zhang YX; Akumuo RC; España RA; Yan CX; Gao WJ; Li YC
    Neuropharmacology; 2018 Oct; 141():113-125. PubMed ID: 30165076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low HOX gene expression in PML-RARα-positive leukemia results from suppressed histone demethylation.
    Rejlova K; Musilova A; Kramarzova KS; Zaliova M; Fiser K; Alberich-Jorda M; Trka J; Starkova J
    Epigenetics; 2018; 13(1):73-84. PubMed ID: 29224413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathologic implication of microRNA-197 in diffuse large B cell lymphoma.
    Yang JM; Jang JY; Jeon YK; Paik JH
    J Transl Med; 2018 Jun; 16(1):162. PubMed ID: 29890998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GSK-J4 Inhibition of KDM6B Histone Demethylase Blocks Adhesion of Mantle Cell Lymphoma Cells to Stromal Cells by Modulating NF-κB Signaling.
    Sadeghi L; Wright APH
    Cells; 2023 Aug; 12(15):. PubMed ID: 37566089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GSK-J4: An H3K27 histone demethylase inhibitor, as a potential anti-cancer agent.
    Dalpatraj N; Naik A; Thakur N
    Int J Cancer; 2023 Sep; 153(6):1130-1138. PubMed ID: 37165737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma.
    Katagi H; Louis N; Unruh D; Sasaki T; He X; Zhang A; Ma Q; Piunti A; Shimazu Y; Lamano JB; Carcaboso AM; Tian X; Seluanov A; Gorbunova V; Laurie KL; Kondo A; Wadhwani NR; Lulla R; Goldman S; Venneti S; Becher OJ; Zou L; Shilatifard A; Hashizume R
    Clin Cancer Res; 2019 Sep; 25(18):5572-5583. PubMed ID: 31227500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in mice.
    Wei Y; Zheng H; Bao N; Jiang S; Bueso-Ramos CE; Khoury J; Class C; Lu Y; Lin K; Yang H; Ganan-Gomez I; Starczynowski DT; Do KA; Colla S; Garcia-Manero G
    Blood Adv; 2018 Oct; 2(19):2491-2504. PubMed ID: 30275007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The H3K27me3 demethylase, KDM6B, is induced by Epstein-Barr virus and over-expressed in Hodgkin's Lymphoma.
    Anderton JA; Bose S; Vockerodt M; Vrzalikova K; Wei W; Kuo M; Helin K; Christensen J; Rowe M; Murray PG; Woodman CB
    Oncogene; 2011 Apr; 30(17):2037-43. PubMed ID: 21242977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological DNA demethylation restores SMAD1 expression and tumor suppressive signaling in diffuse large B-cell lymphoma.
    Stelling A; Wu CT; Bertram K; Hashwah H; Theocharides APA; Manz MG; Tzankov A; Müller A
    Blood Adv; 2019 Oct; 3(20):3020-3032. PubMed ID: 31648327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AURKA Suppresses Leukemic THP-1 Cell Differentiation through Inhibition of the KDM6B Pathway.
    Park JW; Cho H; Oh H; Kim JY; Seo SB
    Mol Cells; 2018 May; 41(5):444-453. PubMed ID: 29477140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fbw7 regulates apoptosis in activated B-cell like diffuse large B-cell lymphoma by targeting Stat3 for ubiquitylation and degradation.
    Yao S; Xu F; Chen Y; Ge Y; Zhang F; Huang H; Li L; Lin D; Luo X; Xu J; Luo D; Zhu X; Liu Y
    J Exp Clin Cancer Res; 2017 Jan; 36(1):10. PubMed ID: 28069035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The histone demethylase KDM6B fine-tunes the host response to Streptococcus pneumoniae.
    Connor MG; Camarasa TMN; Patey E; Rasid O; Barrio L; Weight CM; Miller DP; Heyderman RS; Lamont RJ; Enninga J; Hamon MA
    Nat Microbiol; 2021 Feb; 6(2):257-269. PubMed ID: 33349663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AUY922 effectively targets against activated B cell subtype of diffuse large B-cell lymphoma and low-grade lymphoma cells harboring genetic alteration-associated nuclear factor-κB activation.
    Tsai HJ; Shih NY; Kuo SH; Cheng AL; Lin HY; Chen TY; Chang KC; Lin SF; Chang JS; Chen LT
    Leuk Lymphoma; 2015; 56(9):2674-82. PubMed ID: 25535814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.